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1. Introduction
  Tephrosia purpurea (English–purple Tephrosia, Sanskrit 
-sarapunkha) has been used in the traditional system of 
Indian medicine to treat inflammation, boils and pimples[1]. 
It has been shown to have antiulcer[2] and antioxidant[3] 
activities. There has been no study to evaluate the 
antiinflammatory activity of orally administered ethanolic 
extract of Tephrosia purpurea in both acute and subacute 
inflammation. Hence, the present study was done to 
assess the antiinflammatory activity of orally administered 
ethanolic (using 95% ethanol) extract of Tephrosia purpurea 
in acute and subacute inflammation in rats.
2. Materials and methods 
2.1. Collection and preparation of ethanolic extract of 
Tephrosia purpurea[4]
  The plant, Tephrosia purpurea, was obtained from a local 
shop in Udupi and verification was done by the Department 
of Pharmacognosy, Manipal College of Pharmaceutical 
Sciences, Manipal. The plant parts were cleaned, dried 
under shade and powdered by a mechanical grinder. The 
powder was loaded into soxhlet extractor (Tensil glass 
works, Bangalore, India) in eight batches of 250 g each and 
was subjected to extraction for about 30 - 40 hours with 
95% ethanol. After extraction, the solvent was distilled off 
and the extract was concentrated under reduced pressure 
at a water bath temperature below 50 曟 to a syrupy 
consistency. Then it was dried in the desiccator, (Quality 
traders, Ernakulum, Kerala) finally yielding 73 g from 2 kg 
of dried plant.
2.2. Animal care and handling
  Healthy, albino Wistar rats (150-200) g, 12 weeks old, 
of either sex, bred locally in the animal house of Kasturba 
Medical College, Manipal were used for the study. They 
were housed under controlled conditions of temperature 
(23±2) ℃, humidity (50±5)% and 10-14 hour light 
and dark cycles. The animals were housed individually in 
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polypropylene cages (U.N. Shah manufacturers, Mumbai, 
India) containing sterile paddy husk (produced locally) 
as bedding and were maintained on normal diet (Amrut 
lab animal feed, Pranav Agro Industries Ltd, Sangli, 
Maharashtra) and water ad libitum. Animals were fasted 
for 12 hours before the start of experiment. The study was 
undertaken after obtaining approval of Institutional Animal 
Ethics Committee.
2.3. Study design
  Two models-carrageenan induced paw edema and cotton 
pellet granuloma - were used for acute and subacute 
inflammation respectively.
  Four groups of animals (control, standard and two test 
groups) were used for each model. There were six animals 
in each group in each model. The drug treatment was as 
follows: 
  Group I (control) - 2 mL of 2 % gum acacia orally; Group 
II (standard drug)–aspirin 100 mg/kg body weight of the 
rat orally[5]; Group III (test drug)–ethanolic extract of 
Tephrosia purpurea 500 mg/kg body weight of the rat orally; 
Group IV (test drug)–ethanolic extract of Tephrosia purpurea 
1 000 mg/kg body weight  of the rat orally. 
  The test and standard drugs were administered after 
dissolving them in 2% gum acacia. The dose of the test drug 
was selected based on previous studies[6, 7].
2.3.1. Drugs and chemicals
  Gum acacia (Nice Chemicals, Cochin, India), aspirin 
(Sigma Chemicals, USA), carrageenan (Sigma Chemicals, 
USA), ethanol (Qualigens Fine Chemicals, Mumbai, India), 
normal saline (Fresenius Kabi India Pvt. Ltd).
2.3.2. Acute inflammation model: carrageenan induced paw 
oedema
  Four groups of animals were treated orally with 2 mL 
of 2% gum acacia, 100 mg/kg of aspirin, 500 mg/kg and 
1 000 mg/kg of ethanolic extract of Tephrosia purpurea 
respectively. Sixty minutes later, an injection of 0.1 mL 
of 1% carrageenan in normal saline was made into the 
subplantar region of the right hind paw of each rat in each 
group. The paw volume was measured immediately after 
injection at 0 hours, again at 3 and 6 hours by a digital 
plethysmometer (UGO Basille, Italy)[8,9]. The edema was 
expressed as an increase in paw volume. The difference in 
the initial volume and volume at 3 hrs indicates paw volume 
at 3 hrs. Accordingly, paw volume at 6 hrs was calculated. 
Then percentage of inhibition of edema was calculated for 
each group with respect to the control group as follows:
 Percentage of inhibition of paw edema = (1- Vt/Vc) 暳100
  where Vc and Vt represent average paw volume of control 
and drug treated animals respectively. 
 Blood (2 mL) was collected by retro orbital puncture 
at 0 hrs and at 6 hrs in each rat for estimation of serum 
ceruloplasmin, an acute phase reactant [10].
2.3.3. Subacute inflammation model: cotton pellet granuloma
   Four groups of animals were used in this model. Subacute 
inflammation was produced using cotton pellets[11,12]. Under 
aseptic precautions, an incision was made on the back of each 
rat in each group and sterile cotton pellets (50±1) mg were 
implanted subcutaneously bilaterally in the axilla under 
ether anesthesia. Four groups of animals were treated orally 
with 2 mL of 2% gum acacia, 100 mg/kg of aspirin, 500 mg/kg 
and 1000 mg/kg of Tephrosia purpurea respectively for six 
days. On the seventh day, animals were sacrificed; pellets 
were removed along with the granulation tissue and dried 
at 60 曟for 24 hrs. The net dry weight of the granuloma was 
determined[11].
2.4. Statistical analysis
  Data of paw volume and weight of cotton pellet granuloma 
was analyzed by One Way Analysis of Variance (ANOVA) 
followed by Scheffe’s test. Repeated measure ANOVA was 
used to analyze serum ceruloplasmin values. P< 0.05 was 
considered significant.
3. Results
3.1. Carrageenan induced rat paw edema model
 In the acute inflammation model, there was no significant 
decrease in paw volume and serum ceruloplasmin levels of 
Tephrosia purpurea treated groups as compared to control 
and aspirin treated group. There was a significant (P<0.01) 
decrease in paw volume in aspirin treated group as compared 
to control and groups treated with Tephrosia purpurea (Table 
1). There was a decrease in serum ceruloplasmin levels 
in aspirin treated group (29.21±4.41) mg/dL which was 
significant (P < 0.003) as compared to control (49.99±5.09) 
mg/dL and Tephrosia purpurea treated groups (48.09±3.32)
mg/dL and (45.20±3.18) mg/dL (Table 2).
3.2. Cotton pellet granuloma model
  The dry weight of cotton pellet granuloma in control, 
aspirin and two Tephrosia purpurea treated groups was 
(88.34±12.20) mg, (38.25±8.05) mg, (49.43±5.80) mg 
and (41.72±9.29) mg respectively (Table 3). There was a 
significant (P<0.01) decrease in the dry weight of granuloma 
in aspirin and Tephrosia purpurea treated groups as 
compared to control.
4. Discussion
  The study was done to evaluate the antiinflammatory 
activity of orally administered ethanolic extract of Tephrosia 
purpurea in acute and subacute inflammation in rats.
  Carrageenan, an irritant, is used to induce paw edema. 
Carrageenan induced paw edema in rats is a commonly used 
model to study the antiinflammatory effects of a compound 
in acute inflammation. The ethanolic extract of Tephrosia 
purpurea administered orally did not show any significant 
decrease in paw volume. Aspirin, an antiinflammatory drug, 
decreased the paw volume in rats.
  Serum ceruloplasmin has been reported to increase 
in carrageenan induced paw edema in rats[13]. It was 
significantly decreased in rats treated with aspirin but not in 
Tephrosia purpurea treated rats. Thus, the ethanolic extract 
of Tephrosia purpurea administered orally did not exert 
antiinflammatory effect in acute inflammation.
  The cotton pellet granuloma model for subacute 
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inflammation represents the proliferative phase of 
inflammation which takes place over days. The inhibition 
of proliferative phase by the ethanolic extract of Tephrosia 
purpurea and aspirin could have resulted in a decrease in 
the weight of granuloma formation. 
  Therefore, the ethanolic extract of orally administered 
Tephrosia purpurea has significant antiinflammatory effect in 
subacute inflammation. Its antiulcerogenic properties could 
be an advantage. Further studies need to be conducted to 
compare it with antiinflammatory agents like corticosteroids 
which commonly cause peptic ulcer as a side effect.   
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Table 1     




Mean increase in paw volume in mL at  Percent   inhibition at 
  3h  6 h 3 h  6 h 
Group I/Gum acacia    2 mL  0. 43±0.02   0. 41±0.08 - - 
Group II/ Aspirin  100 mg/kg    0.21±0.01a     0.18±0.02a  51.16 56.09 
Group III/ T. purpurea 500 mg/kg   0.42±0.04    0.38±0.06 2.32 6.97
Group IV/T. purpurea 1 000 mg/kg   0.39±0.01     0.36±0. 02 9.30 12.19
 T. purpurea–Tephrosia purpurea, values are expressed as Mean ± SEM, aP < 0.01 vs control, Tephrosia purpurea treated groups.
Table 2   
Effect of ethanolic extract of Tephrosia purpurea on serum ceruloplasmin  in acute  inflammation.
Group/Drug Dose
Serum ceruloplasmin (mg/dL)
 0 h 6 h
Group I/Gum acacia     2 mL  24.95±2.90 49.99±5.09
Group II/Aspirin  100 mg/kg  23.27±4.74  29.21±4.41a
Group III/Tephrosia purpurea 500 mg/kg  28.04±6.72 48.09±3.32
Group IV/Tephrosia purpurea 1 000 mg/kg  31.99±6.98 45.20±3.18 
 Values are expressed as Mean ± SD, aP< 0.003 vs control, Tephrosia purpurea treated groups.   
Table 3   
Effect of ethanolic extract of Tephrosia purpurea on cotton pellet granuloma  in rats.
Group/  Drug Dose Dry weight (mg)of granuloma
% inhibition of  granuloma 
formation
Group I /Gum acacia    2 mL    88.34±12.20 -  
Group II / Aspirin 100 mg/kg  38.25±8.05a  56.70
Group III /Tephrosia purpurea 500 mg/kg  49.43±5.80a 44.04
Group IV / Tephrosia purpurea 1 000 mg/kg  41.72±9.29a 52.77
Values expressed as Mean ± SEM, aP < 0.01 vs control.
